|
|
Pulse Biosciences Inc (PLSE) |
|
|
|
Pulse Biosciences Inc 's Yearly Net Cash Flow Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Net Cash Flow Annual Growth Rates Y/Y▼
|
Annual Net Cash Flow Annual Growth Rates Y/Y▼
|
PLSE Annual Net Cash Flow Growth |
2022
|
2021
|
2020
|
2019
|
2018
|
Y / Y Annual Net Cash Flow Change |
101.38 % |
190.28 % |
- |
- |
3579.03 % |
Annual Net Cash Flow (in millions $) |
$32.53 |
$16.15 |
$5.56 |
$-44.20 |
$47.72 |
Annual Net Cash Flow Growth
Comment |
Pulse Biosciences Inc 's Annual Net Cash Flow for the fiscal year ended 2022, more than doubled to 101.38% to $32.53 millions, from $16.15 millions achieved a year ago. Pulse Biosciences Inc 's 2022 Annual Net Cash Flow performance marks a slow down, from 190.28 % achieved in the fiscal year 2021.
Pulse Biosciences Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2022 Annual Net Cash Flow within Healthcare Sector | Y/Y Net Cash Flow Growth % | 2022 Annual Net Cash Flow | Abbott Laboratories | -97.20 % | $ 83.000 millions | Novavax inc | | | |